Castle Biosciences, Inc. (CSTL) Financials

CSTL Assets vs Liabilities

DateAssetsLiabilities
2024-03-31 458.5 million 56.0 million
2023-12-31 477.8 million 86.5 million
2023-09-30 436.0 million 50.2 million
2023-06-30 425.4 million 46.6 million

CSTL Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2024-03-31 -16.0 million 12.7 million
2023-12-31 20.3 million 11.8 million
2023-09-30 2.6 million 13.0 million
2023-06-30 -7.8 million 12.8 million

CSTL Net Income

No data available :(

CSTL Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2024-03-31 239.2 million - 15.1 million
2023-12-31 243.1 million - 15.3 million
2023-09-30 229.8 million - 14.5 million
2023-06-30 225.5 million - 14.4 million

CSTL Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2024-03-31 27.5 million
2023-12-31 27.0 million
2023-09-30 26.8 million
2023-06-30 26.7 million

CSTL Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2024-03-31 9.2 million 13.5 million 48.5 million -
2023-12-31 3.8 million 12.9 million 17.1 million 27.0 million
2023-09-30 2.5 million 12.9 million 16.1 million 28.5 million
2023-06-30 4.0 million 13.3 million 16.4 million 28.3 million

CSTL Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2024-03-31 73.0 million 16.6 million
2023-12-31 66.1 million 15.1 million
2023-09-30 61.5 million 11.3 million
2023-06-30 50.1 million 11.1 million

CSTL

Price: $24.24

52 week price:
9.26
26.70

Earnings Per Share: -1.13 USD

P/E Ratio: -8.24

Exchange: NGM

Sector: Healthcare

Industry: Diagnostics & Research

Volume: 126500

Market Capitalization: 656.9 million

Links: